Systematic Review and Meta-analysis of Short-Term Outcomes in Patients Following Protected High-Risk PCI
Highlights • The use of Impella during high-risk percutaneous coronary intervention (PCI) is increasing, yet current evidence is limited to registry-based data. No robust prospective trials have established its safety…
read more